• Home
  • About
  • Our Team
  • Current Trials
    • MCI/Alzheimers Disease
    • Multiple Sclerosis
    • Parkinson's Disease
    • Migraine
    • Agitation in TBI
    • Obsessive Compulsive Disorder
    • Epilepsy
  • Previous Trials
  • Contact
NRC
  • Home
  • About
  • Our Team
  • Current Trials
    • MCI/Alzheimers Disease
    • Multiple Sclerosis
    • Parkinson's Disease
    • Migraine
    • Agitation in TBI
    • Obsessive Compulsive Disorder
    • Epilepsy
  • Previous Trials
  • Contact

Multiple Sclerosis

Relapsing Multiple Sclerosis

EMD SERONO
A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared with Aubagio, in Participants with Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety.

F. HOFFMANN-LA ROCHE LTD
AN OBSERVATIONAL STUDY OF OCRELIZUMAB-TREATED PATIENTS WITH MULTIPLE SCLEROSIS TO DETERMINE THE INCIDENCE AND MORTALITY RATES OF BREAST CANCER AND ALL MALIGNANCIES (VERISMO STUDY)
Picture
wiki media LarrabeeMGH
Neuroscience Research Center, LLC.
4048 Dressler Rd
Canton, Ohio 44718
330-244-2542
fax: 330-244-2541

email:  nrc@neurocarecenter.com
  • Home
  • About
  • Our Team
  • Current Trials
    • MCI/Alzheimers Disease
    • Multiple Sclerosis
    • Parkinson's Disease
    • Migraine
    • Agitation in TBI
    • Obsessive Compulsive Disorder
    • Epilepsy
  • Previous Trials
  • Contact